RecruitingNCT06529029
This study is looking at whether Sigma-Stim can help people with Suicidal Ideation, depression, Schizo Affective Disorder, or bipolarity. Participants take part in Sigma-Stim and complete follow-up assessments.
DepressionDeviceFrom 18 Years to 90 Years
- Countries
- United States
- Sponsor
- Michigan State University
- Condition
- Depression
Active Not RecruitingNCT03484494
This observational study is following people with bipolarity, Depression in bipolarity, Bipolarity I, or Bipolarity II to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
BipolarityDeviceOver 50 Years
- Countries
- United States
- Sponsor
- Mclean Hospital
- Condition
- Bipolarity
RecruitingNCT06482762
This study is looking at whether cognitive behavioural therapy can help people with Bipolar. Participants receive a study treatment and complete follow-up visits and assessments.
BipolarityDeviceFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- Massachusetts General Hospital
- Condition
- Bipolarity
Enrolling By InvitationNCT05199870
This observational study is following people with Hip Arthritis, Hip Disease, Hip Fractures, or Hip Injuries to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
BipolarityOtherOver 18 Years
- Countries
- United States
- Sponsor
- Zimmer Biomet
- Condition
- Bipolarity
RecruitingNCT04080778
This study is looking at whether magnetic seizure therapy (MST) can help people with bipolarity. Participants take part in magnetic seizure therapy (MST) and complete follow-up assessments.
BipolarityDeviceFrom 22 Years to 85 Years
- Countries
- United States
- Sponsor
- Joao L. DeQuevedo
- Condition
- Bipolarity
Enrolling By InvitationNCT06792175
This observational study is following people with depression, anxiety, psychosis, or bipolarity to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
DepressionOtherFrom 13 Years to 60 Years
- Countries
- United States
- Sponsor
- Psyrin Inc.
- Condition
- Depression
Enrolling By InvitationNCT06880796
This study is looking at whether a digital support tool can help people with Serious Mental Illness, Schizophrenia, depression, or bipolarity. Participants take part in a digital support tool and complete follow-up assessments.
DepressionOtherOver 18 Years
- Countries
- United States
- Sponsor
- Butler Hospital
- Condition
- Depression
Active Not RecruitingNCT05272046
This study is looking at care and outcomes for people with Esophageal Motility Disorders. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
BipolarityProcedureOver 18 Years
- Countries
- United States, India, Spain
- Sponsor
- Baylor College of Medicine
- Condition
- Bipolarity
RecruitingNCT06372964
This study is comparing Lumateperone with placebo for people with Depression in bipolarity. Participants receive Lumateperone or placebo and complete study visits and assessments.
BipolarityDrugFrom 10 Years to 17 Years
- Countries
- United States, India, Serbia
- Sponsor
- Intra-Cellular Therapies, Inc.
- Condition
- Bipolarity
RecruitingNCT05669703
This observational study is following people with bipolarity, Major Depression, or Migraine to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
BipolarityOtherFrom 8 Years to 70 Years
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH)
- Condition
- Bipolarity
Not Yet RecruitingNCT05457127
This study is looking at examine feasibility, acceptance, and impact of OSA treatment and how it affects cognitive function in people with SMI for people with schizoaffective disorder, Schizophrenia, bipolarity, or Obstructive Sleep Apnea of. Taking part may give some people access to Automatic Positive Airway Pressure (APAP), but direct benefit is not guaranteed.
SchizophreniaDeviceFrom 40 Years to 70 Years
- Countries
- United States
- Sponsor
- University of California, San Diego
- Condition
- Schizophrenia
Enrolling By InvitationNCT06558201
This study is looking at care and outcomes for people with Bipolarity I, schizoaffective disorder, or Psychosis. Taking part may give some people access to Ketogenic diet, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- United States
- Sponsor
- Mclean Hospital
- Condition
- Schizophrenia
RecruitingNCT05699525
This study is looking at whether cognitive behavioural therapy can help people with anxiety and Symptoms, Depression, bipolarity, or Symptoms. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
BipolarityBehavioralFrom 18 Years to 25 Years
- Countries
- United States
- Sponsor
- Weill Medical College of Cornell University
- Condition
- Bipolarity
Active Not RecruitingNCT05065294
This study is looking at determine the safety, tolerability, and feasibility of psilocybin therapy in people with Bipolarity II. Participants receive a study treatment and complete follow-up visits and assessments.
BipolarityDrugFrom 18 Years to 70 Years
- Countries
- United States
- Sponsor
- University of California, San Francisco
- Condition
- Bipolarity
Enrolling By InvitationNCT00762866
This observational study is following people with major depression, bipolarity, or psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
DepressionOtherFrom 16 Years to 65 Years
- Countries
- United States
- Sponsor
- Vanderbilt University
- Condition
- Depression
RecruitingNCT07266545
This study is looking at care and outcomes for people with Unipolar Depression or Depression in bipolarity. Taking part may give some people access to Vortioxetine, but direct benefit is not guaranteed.
BipolarityDrugFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Mayo Clinic
- Condition
- Bipolarity
Active Not RecruitingNCT07043803
This study is looking at whether a digital support tool can help people with Schizophenia Disorder, schizoaffective disorder, or bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- University of Pittsburgh
- Condition
- Schizophrenia
RecruitingNCT05648591
This study is looking at care and outcomes for people with Schizophrenia or Bipolarity I. Taking part may give some people access to Iloperidone, but direct benefit is not guaranteed.
SchizophreniaDrugFrom 12 Years to 17 Years
- Countries
- United States
- Sponsor
- Vanda Pharmaceuticals
- Condition
- Schizophrenia
Active Not RecruitingNCT06433635
This study is looking at whether a digital support tool can help people with Bipolarity I or Depression. Participants receive a study treatment and complete follow-up visits and assessments.
BipolarityDrugFrom 18 Years to 75 Years
- Countries
- United States, Canada
- Sponsor
- Massachusetts General Hospital
- Condition
- Bipolarity
RecruitingNCT07402954
This study is looking at whether a digital support tool can help people with Migraine. Participants take part in a digital support tool and complete follow-up assessments.
BipolarityDeviceFrom 18 Years to 100 Years
- Countries
- United States
- Sponsor
- The University of Texas Medical Branch, Galveston
- Condition
- Bipolarity
RecruitingNCT00025935
This observational study is following people with mood conditions to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
BipolarityDrugFrom 7 Years to 60 Years
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH)
- Condition
- Bipolarity
RecruitingNCT07046494
This study is comparing RAP-219 with placebo for people with Bipolarity type I. Participants receive RAP-219 or placebo and complete study visits and assessments.
BipolarityDrugFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Rapport Therapeutics Inc.
- Condition
- Bipolarity
RecruitingNCT06869187
This study is looking at whether ABX-002 can help people with bipolarity Depression. Participants receive a study treatment and complete follow-up visits and assessments.
BipolarityDrugFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Autobahn Therapeutics, Inc.
- Condition
- Bipolarity
RecruitingNCT06462586
This observational study is following people with bipolarity, Manic to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
BipolarityDrugFrom 18 Years to 75 Years
- Countries
- United States, Bulgaria, Croatia, India, Serbia
- Sponsor
- Intra-Cellular Therapies, Inc.
- Condition
- Bipolarity
RecruitingNCT06462612
This observational study is following people with bipolarity, Manic to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
BipolarityDrugFrom 18 Years to 75 Years
- Countries
- United States, Bulgaria, Romania, Serbia
- Sponsor
- Intra-Cellular Therapies, Inc.
- Condition
- Bipolarity